Body composition measurements and clinical outcomes in patients with resectable pancreatic adenocarcinoma – analysis from SWOG S1505
- 20 January 2024
- journal article
- research article
- Published by Elsevier in Journal of Gastrointestinal Surgery
- Vol. 28 (3) , 232-235
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Sarcopenia: Beyond Muscle Atrophy and into the New Frontiers of Opportunistic Imaging, Precision Medicine, and Machine LearningSeminars in Musculoskeletal Radiology, 2018
- Preoperative sarcopenia and post‐operative accelerated muscle loss negatively impact survival after resection of pancreatic cancerJournal of Cachexia, Sarcopenia and Muscle, 2018
- Decreased Skeletal Muscle Volume Is a Predictive Factor for Poorer Survival in Patients Undergoing Surgical Resection for Pancreatic Ductal AdenocarcinomaJournal of Gastrointestinal Surgery, 2018
- Visceral Adiposity and Sarcopenic Visceral Obesity are Associated with Poor Prognosis After Resection of Pancreatic CancerAnnals of Surgical Oncology, 2017
- Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma: A retrospective cohort studyInternational Journal of Surgery, 2017
- Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancerJournal of Cachexia, Sarcopenia and Muscle, 2016
- Effect of sarcopenia and visceral obesity on mortality and pancreatic fistula following pancreatic cancer surgeryBritish Journal of Surgery, 2016
- Characterization of Anthropometric Changes that Occur During Neoadjuvant Therapy for Potentially Resectable Pancreatic CancerAnnals of Surgical Oncology, 2014
- Cachexia in Patients with Chronic Pancreatitis and Pancreatic Cancer: Impact on Survival and OutcomeNutrition and Cancer, 2013
- Cachexia but not obesity worsens the postoperative outcome after pancreatoduodenectomy in pancreatic cancerSurgery, 2012